Stock news timeline · JENBURPH
News timeline · Last 30 days
23 Aug 2026 – 21 Sep 2026 · Times in IST
Showing 4 of 4 updates · Newest first
Change the keyword or sentiment above, then click Apply.
Jenburkt Pharmaceuticals announced the resignation of Mr. Vinay Bhatt, Sr. VP-International Business, effective 18th Sept 2026. Resignation due to personal reasons; details and resignation letter available on the company's website. Source: BSE
Jenburkt Pharmaceuticals reappoints Shri Dilip H. Bhuta as Whole Time Director & CFO for 5 years from Apr 2027 to Mar 2032. Shareholders approved his tenure extension and remuneration for 3 years; details available on company website. Source: BSE
Jenburkt Pharmaceuticals' AGM approved all resolutions with requisite majority, including dividend declaration and director reappointments. Voting results and scrutinizer's report are accessible on company and NSDL websites; resolutions included cost auditor remuneration ratification. Source: BSE
Jenburkt Pharma elevates Prem Ashish Bhuta to AVP-Strategic Initiatives effective 4th Sep 2026. Bhuta, with 5 years' pharma experience, aided ZIXA Strong launch and tech modernization efforts. Source: BSE